You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'IL-17F'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15 KDa. Observed: 15 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.8 KDa. Observed: 19-22 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1&17.8 KDa. Observed: 15-22 KDa, reducing conditions
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.7 KDa. Observed: 18-22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.9 KDa. Observed: 18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 15.1&16 KDa. Observed: 15-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.9 KDa. Observed: 17-23 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.96 KDa. Observed: 19 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Featured
Active
Item 1 of 1FeaturedActive> 95% as determined by SDS-PAGE and HPLC.
15 kDa
E.Coli
5 μg, 100 μg, 500 μg - FeaturedActiveItem 1 of 1Human IL17F protein [orb594813]FeaturedActive
Greater than 95% as determined by SDS-PAGE.
14.9 kDa
E.coli
10 μg, 50 μg, 1 mg, 500 μg
